Drug Profile
Acidified nitrite - Arch Biopartners/University of Cincinnati
Alternative Names: A-NO2− - Arch Biopartners/University of Cincinnati; AB 569; ABP-569Latest Information Update: 28 Jun 2023
Price :
$50
*
At a glance
- Originator University of Cincinnati
- Developer Arch Biopartners; University of Cincinnati
- Class Anions; Antibacterials; Antihypertensives; Nitrites; Nitrogen compounds; Organic chemicals; Vasodilators
- Mechanism of Action Nitric oxide stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections; Burkholderia cepacia infections; Pseudomonal infections; Staphylococcal infections
Most Recent Events
- 28 Jun 2023 No recent reports of development identified for phase-I development in Bacterial-infections(Treatment-resistant) in USA (Inhalation)
- 28 Jun 2023 No recent reports of development identified for phase-I development in Pseudomonal-infections(In volunteers) in USA (Inhalation, Liquid)
- 28 Jun 2023 No recent reports of development identified for phase-I development in Pseudomonal-infections(Treatment-resistant) in USA (Inhalation, Liquid)